Brenus Pharma Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 25

Employees

  • Latest Deal Type
  • Series A1

  • Latest Deal Amount
  • $14.8M

  • Investors
  • 12

Brenus Pharma General Information

Description

Developer of an immuno-oncology platform designed to develop immunotherapies for the treatment of resistant and evolving solid tumors. The company offers a stimulated-ghost-cell platform that produces allogeneic ghost-cell immunotherapies and utilizes data-driven development and scalable manufacturing processes, enabling oncology healthcare providers and cancer patients to access targeted immunotherapies for hard-to-treat tumors.

Contact Information

Website
www.brenus-pharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 4 Rue Eric De Cromieres
  • 63000 Clermont-Ferrand
  • France
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 4 Rue Eric De Cromieres
  • 63000 Clermont-Ferrand
  • France

Brenus Pharma Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Brenus Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A1) 15-May-2026 $14.8M Completed Pre-Clinical Trials
6. Later Stage VC (Series A) 04-Jul-2024 Completed Pre-Clinical Trials
5. Accelerator/Incubator 01-Jan-2023 Completed Pre-Clinical Trials
4. Seed Round 17-Mar-2022 Completed Startup
3. Angel (individual) 06-Oct-2020 Completed Startup
2. Angel (individual) 23-Oct-2018 $573K $573K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Brenus Pharma’s complete valuation and funding history, request access »

Brenus Pharma Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
To view Brenus Pharma’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Brenus Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Brenus Pharma Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angelor Venture Capital Minority
Credit Agricole Investment Bank Minority
Crédit Agricole Centre France Développement Corporation Minority
Noshaq Venture Capital Minority
ORSA FUND Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

Brenus Pharma FAQs

  • When was Brenus Pharma founded?

    Brenus Pharma was founded in 2014.

  • Where is Brenus Pharma headquartered?

    Brenus Pharma is headquartered in Clermont-Ferrand, France.

  • What is the size of Brenus Pharma?

    Brenus Pharma has 25 total employees.

  • What industry is Brenus Pharma in?

    Brenus Pharma’s primary industry is Drug Discovery.

  • Is Brenus Pharma a private or public company?

    Brenus Pharma is a Private company.

  • What is the current valuation of Brenus Pharma?

    The current valuation of Brenus Pharma is .

  • What is Brenus Pharma’s current revenue?

    The current revenue for Brenus Pharma is .

  • How much funding has Brenus Pharma raised over time?

    Brenus Pharma has raised $44.8M.

  • Who are Brenus Pharma’s investors?

    Angelor, Credit Agricole, Crédit Agricole Centre France Développement, Noshaq, and ORSA FUND are 5 of 12 investors who have invested in Brenus Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process